Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Do Homeodomain Interacting Protein Kinase 2 (HIPK2) Polymorphisms rs2058265, rs6464214, and rs7456421 Associate With Nephrolithiasis in Turkish Population?

NCT04804436 is registered in ClinicalTrials.gov with Saglik Bilimleri Universitesi as lead sponsor.

NCT NCT04804436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04804436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Do Homeodomain Interacting Protein Kinase 2 (HIPK2) Polymorphisms rs2058265, rs6464214, and rs7456421 Associate With Nephrolithiasis in Turkish Population?
Lead sponsor
Saglik Bilimleri Universitesi
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2018
Completion date
October 6, 2019
Enrollment
196 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney stone